Precision Health is an ambitious plan that will drive three outcomes:
Cure at least one cancer through the development of new cell, gene and immune therapies
Develop novel disease modifying or prevention methods for adult neurodegenerative diseases such as Alzheimer’s Disease
Use gene and other therapies to cure at least one genetic pediatric disease
This initiative will work closely with several prominent business and community partners, including Eli Lilly and Co., Roche Diagnostics, Cook Regentec, Deloitte, Regenstrief Institute and IU Health.